Item 1.01. Entry into a Material Definitive Agreement.
On November 4, 2021, Artemis Therapeutics, Inc. (the "Company") issued two
unsecured promissory notes (each, a "Note" and collectively the "Notes") in the
aggregate principal amount of $60,000, with original issuance dates of September
19, 2021 and August 15, 2021. In that regard, one Note, with a principal
aggregate balance of $30,000, was issued to KNRY Ltd., an entity related
to Nadav Kidron, the natural person with voting and dispositive power over the
securities held by Tonak Ltd., the Company's largest shareholder. In addition,
one Note, with an aggregate principal balance of $30,000, was issued to Harmony
(H.A.) Investments Ltd. Each Note accrues interest at a rate of 10% per annum
until the Note is repaid in full. All payments of principal, interest and other
amounts under each Note are payable by December 19, 2021. The proceeds of the
Notes will be used by the Company for general working capital purposes.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation Under an
Off-Balance Sheet Arrangement of the Registrant.
The information included in Item 1.01 of this Current Report on Form 8-K is
hereby incorporated by reference into this Item 2.03.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number Exhibit Description
Exhibit 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded
within the Inline XBRL document.
© Edgar Online, source Glimpses